D-1392-2019 Class III Terminated

Recalled by Akorn Inc — Lake Forest, IL

FDA drug recall D-1392-2019 was initiated by Akorn Inc on Jun 7, 2019 and is designated Class III. Reason for recall: Labeling: Label mix-up: Product secondary carton erroneously states 40mg instead of 30 mg, primary carton is label correctly. The recall status is terminated (terminated Jul 28, 2022). Affected quantity: 16,216 cartons.

Recall details

Product Type
Drugs
Report Date
Jun 26, 2019
Initiation Date
Jun 7, 2019
Termination Date
Jul 28, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
16,216 cartons

Product description

Myorisan (isotretinoin capsules, USP), 40 mg, packaged in cartons of 30 Capsules containing 3 x 10 Prescription Packs, Rx Only, Distributed by: VersaPharm Inc. - An Akorn Company, Lake Forest, IL 60045, NDC 61748-304-13

Reason for recall

Labeling: Label mix-up: Product secondary carton erroneously states 40mg instead of 30 mg, primary carton is label correctly.

Distribution pattern

Nationwide USA

Code information

Lot#: V30M56A, Exp 9/20

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1392-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1392-2019. Report a data issue: hello@regdatalab.com.